Intracoronary verapamil administration was independently associated with successful myocardial reperfusion immediately after PCI in patients with angiographic no-reflow (OR 22.4; P=0.002).
Cohort (n=101)
Does intracoronary verapamil improve myocardial perfusion and functional recovery in patients with angiographic no-reflow after primary PCI for acute myocardial infarction?
Intracoronary verapamil administration in patients with angiographic no-reflow after primary PCI is associated with improved myocardial perfusion and functional recovery at 1 month.
Effect estimate: OR 22.4
p-value: p=0.002
OBJECTIVE: Angiographic thrombolysis in myocardial infarction (TIMI) flow grade < or = 2 after primary percutaneous coronary intervention (PCI), defined as angiographic no-reflow, predicts poor functional recovery in patients with acute myocardial infarction. We investigated the effect of verapamil on the restoration of myocardial perfusion and functional recovery in patients with angiographic no-reflow after PCI. METHODS: 99mTc tetrofosmin single photon emission computed tomographic (SPECT) imaging was performed (before, immediately after and 1 month after PCI) in 101 consecutive patients with acute myocardial infarction. The defect score was calculated as the sum of perfusion defect in a 13-segment model (scores of 3, complete defect to 0, normal perfusion). The asynergic score, defined as the number of asynergic segments, was assessed by echocardiography before and 1 month later. Multiple logistic regression analysis was performed to elucidate the effect of verapamil administration. RESULTS: Of 101 patients, 32 (31%) had angiographic no-reflow and were divided into two groups: 18 patients with verapamil (group 1) and 14 patients without verapamil (group 2). Sixty-nine patients had TIMI grade 3 reflow after PCI (group 3). The change in the defect score 1 month after PCI in group 1 was significantly larger than that in group 2 (P = 0.003). The asynergic score improved more at 1 month in group 1 compared to that in group 2 (P = 0.007). Moreover, logistic regression analysis revealed that TIMI grade reflow < or = 2 after PCI (P = 0.04, OR = 5.51), the defect score before PCI (P = 0.03, OR = 1.15), the asynergic score before PCI (P = 0.01, OR = 0.64) and the administration of verapamil (P = 0.002, OR = 22.4) were independently associated with successful myocardial reperfusion immediately after PCI. CONCLUSIONS: Intracoronary verapamil restored myocardial perfusion in patients with angiographic no-reflow after PCI and lead to better functional recovery after acute myocardial infarction.
Umemura et al. (Tue,) conducted a cohort in Acute myocardial infarction with angiographic no-reflow after primary PCI (n=101). Intracoronary verapamil vs. No verapamil was evaluated on Successful myocardial reperfusion immediately after PCI (OR 22.4, p=0.002). Intracoronary verapamil administration was independently associated with successful myocardial reperfusion immediately after PCI in patients with angiographic no-reflow (OR 22.4; P=0.002).